NCT02996058View on ClinicalTrials.gov

Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

July 31, 2018

Conditions
Sedation
Interventions
DRUG

Dexmedetomidine 0.35µg/kg /h

the infants will receive a maintenance dose of 0.35µg/kg /h of Dexmedetomidne without a loading dose and guided by the assessed sedation scale

DRUG

Dexmedetomidine 0.5µg/kg /h

the infants will receive a maintenance dose of 0.5µg/kg /h of Dexmedetomidne without a loading dose and guided by the assessed sedation scale

Trial Locations (1)

715715

Pediatric hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02996058 - Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure | Biotech Hunter | Biotech Hunter